scispace - formally typeset
P

Paul M. Matthews

Researcher at Imperial College London

Publications -  641
Citations -  102773

Paul M. Matthews is an academic researcher from Imperial College London. The author has contributed to research in topics: Multiple sclerosis & White matter. The author has an hindex of 140, co-authored 617 publications receiving 88802 citations. Previous affiliations of Paul M. Matthews include John Radcliffe Hospital & King's College London.

Papers
More filters
Journal ArticleDOI

A new view of the cortex, new insights into multiple sclerosis

Christiane Wegner, +1 more
- 01 Aug 2003 - 
TL;DR: A powerful approach to understanding the clinical significance of this pathology would be to follow changes in vivo, when they can be related directly with symptoms and signs.
Posted ContentDOI

Nonlinear biomarker interactions in conversion from Mild Cognitive Impairment to Alzheimer’s disease

TL;DR: The results showed that closely-related biomarkers still contribute uniquely to the prediction of conversion, supporting the continued use of comprehensive biological assessments and nonlinear interaction modelling shows that although for some patients adding additional biomarkers may add little value, for others (i.e., with low hippocampal volume) further invasive and expensive testing is warranted.
Journal ArticleDOI

Functional magnetic resonance imaging: clinical applications and potential.

TL;DR: FMRI can be used to map increases in blood flow that accompany local synaptic activity in the brain, and applications to neurological impairments that are not associated with structural abnormalities, such as learning problems, dyslexia and movement disorders are likely.
Journal ArticleDOI

Rapid rates of newly synthesized mitochondrial protein degradation are significantly affected by the generation of mitochondrial free radicals

TL;DR: It is shown that elevated mitochondrial ROS increases the degradation of newly synthesized mitochondrial proteins with some proteins more sensitive than others, which may trigger a vicious cycle of mitochondrial ROS production.